about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansIdentification of hyaluronic acid binding sites in the extracellular domain of CD44Versican and the regulation of cell phenotype in diseaseHistochemical localisation of versican, aggrecan and hyaluronan in the developing condylar cartilage of the fetal rat mandibleEndocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesisIn situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilageDevelopment of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.Versican and the control of inflammation.Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.The versican C-type lectin domain recognizes the adhesion protein tenascin-R.Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.Isolation and characterisation of a hyaluronan binding protein, hyaluronectin, from human placenta and its colocalisation with hyaluronan.Isolation and purification of versican and analysis of versican proteolysis.Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions.Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.Versican mediates mesenchymal-epithelial transition.Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signalingSegmental versican expression in the trabecular meshwork and involvement in outflow facilityVersican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study.Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.Neuronally produced versican V2 renders C-fiber nociceptors IB4 -positiveProteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-betaSelective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican.Clinical characterisation and molecular analysis of Wagner syndromeBEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to the brain.CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma.Hyaluronan-dependent pericellular matrix.Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronanHyaluronan as a therapeutic target in human diseasesADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections.Three mechanisms assemble central nervous system nodes of Ranvier.GDNF hyperalgesia is mediated by PLCgamma, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican.Homotypic versican G1 domain interactions enhance hyaluronan incorporation into fibrillin microfibrilsBiochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-alpha-inhibitor (HC*HA) purified from extracts of human amniotic membrane.
P2860
Q21710680-45273D9F-0DF1-4657-9EAF-3F3BC0A03B9DQ24674652-5CBD080F-040B-4235-9D2D-7BC88B03AEC1Q27690926-FD683323-0832-486C-8105-5F2107318BBEQ28361483-CF9B5454-5B51-47A3-A81F-FBE1AF9CA07FQ28511878-45CFFDFF-6CA0-43F8-8D98-FE70A6C25458Q28589508-224EFFD6-1FA3-408A-BA24-8A3E60E6E1C8Q30655322-9451A080-97D8-46DC-8DE1-CE5809F89D56Q33648190-C73AD337-3039-4FC0-9153-BF93D0F66723Q33690423-1CB6A61C-9ED8-471C-9F35-BC0CC0B9A0FDQ33747782-BB57AFDA-19D4-4B8B-9FD4-496FAA55C5DAQ33786780-C9CC66F7-BDF3-478A-952F-D01524555142Q33801290-797D6926-6A0F-4F68-B85A-615D74FAD038Q33880848-D8E96192-04B1-435A-8459-6E93AD8C3FFDQ33925643-68033837-65C4-4F67-B4F6-10F58EDA4715Q34133039-95D4B50D-7512-45CD-81E3-4B713040A681Q34135482-C9254F0D-C549-4763-AEE2-6E2CA30D6E8EQ34283551-A0ABB50F-4F68-4744-B6AF-720F9AF79C33Q34365807-C0067F15-4B88-4CD7-9DF5-FC70E82B1F10Q34396542-485DBA16-A9A1-4CF3-A182-1896BB7EE55BQ34483586-93686B8E-64B3-40EC-8B32-C8A489674EEFQ34886935-323D83FD-050B-45BB-B032-65F75737CD5DQ35221423-549C01F5-BF93-4F98-9707-6FFB3BC713DAQ35587767-AE5C001A-6DDD-41BC-BFBA-4806D8DF60D0Q35629808-9689C0E0-70EA-437C-BAE6-8B7A5FAF9BCAQ35756281-70542720-650A-48F0-8B66-C4FAFCBEFED0Q35763762-67BBBF22-B81B-4168-8DB3-8B90737CFD38Q35763997-D8BEF9D2-00AC-4330-9E8A-507D7EF43BDAQ35770507-A84BB0AA-BD5A-4E5F-A90F-8EECD5157B60Q35795327-A22EE0A6-135B-4036-9987-9B2FB6BE4E28Q35953689-7783B895-2716-429A-A627-8B790BC333A4Q36234163-FD69DB00-D6F1-46A4-9C7E-D59FCFBE667FQ36237249-27673A8D-6719-4E94-A855-62BDA479D73DQ36326687-BBECFED6-BBE8-4C49-9084-41BCB7C6A385Q36499699-661116D8-9871-4C66-A23D-734B907D10CEQ36578627-1BF0EFE2-BD30-4C96-8CD1-6B7FC618EBDDQ36672030-88145572-65EB-485C-93DF-55EA1D731782Q37130251-DFAE8D2D-3482-48DB-BAFF-FA2036446255Q37139747-B1F0911F-A0B7-4230-9D82-9AC7F9DB365AQ37213946-173AD938-59C1-447F-B4AB-780AFE0461C2Q37339027-704462B5-47B9-4100-8C95-0A96424D3B09
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Hyaluronate binding properties of versican.
@en
type
label
Hyaluronate binding properties of versican.
@en
prefLabel
Hyaluronate binding properties of versican.
@en
P2093
P1476
Hyaluronate binding properties of versican.
@en
P2093
LeBaron RG
Ruoslahti E
Zimmermann DR
P304
10003-10010
P407
P577
1992-05-01T00:00:00Z